Related references
Note: Only part of the references are listed.Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
Guo-Zhong Yi et al.
BRAIN (2019)
Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
Ryan C. Gimple et al.
CANCER DISCOVERY (2019)
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
Zhen Dong et al.
CANCER DISCOVERY (2019)
Classification of glioma based on prognostic alternative splicing
Yaomin Li et al.
BMC MEDICAL GENOMICS (2019)
RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3
Yonatan Perez et al.
BRAIN (2018)
PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells
Athena Georgilis et al.
CANCER CELL (2018)
miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma
Yaomin Li et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Single-cell transcriptome analysis of lineage diversity in high-grade glioma
Jinzhou Yuan et al.
GENOME MEDICINE (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9
Chun-Song Yang et al.
MOLECULAR CELL (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy
Kirk E. Cahill et al.
NEURO-ONCOLOGY (2016)
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Nakhle S. Saba et al.
BLOOD (2016)
Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner
Sung-Hak Kim et al.
CANCER CELL (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Amy R. Cameron et al.
CIRCULATION RESEARCH (2016)
PARP6 acts as a tumor suppressor via downregulating Survivin expression in colorectal cancer
Guangying Qi et al.
ONCOTARGET (2016)
Targeting NF-kappa B in glioblastoma: A therapeutic approach
Dinorah Friedmann-Morvinski et al.
SCIENCE ADVANCES (2016)
Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma
Bruna R. Correa et al.
GENOME BIOLOGY (2016)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
High antitumor activity of pladienolide B and its derivative in gastric cancer
Momoko Sato et al.
CANCER SCIENCE (2014)
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
Thanh U. Barbie et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Family-wide analysis of poly(ADP-ribose) polymerase activity
Sejal Vyas et al.
NATURE COMMUNICATIONS (2014)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system
Amy E. Lin et al.
NATURE IMMUNOLOGY (2013)
Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10
Patricia Verheugd et al.
NATURE COMMUNICATIONS (2013)
PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development
Handan Tuncel et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The spliceosome as a target of novel antitumour drugs
Sophie Bonnal et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO
Yuri Shibata et al.
NATURE COMMUNICATIONS (2012)
NFκB inhibitors induce cell death in glioblastomas
Alfeu Zanotto-Filho et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Pierre A. Robe et al.
BMC CANCER (2009)
The SR protein family
Peter J. Shepard et al.
GENOME BIOLOGY (2009)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 I.: Taxonomy, fermentation, isolation and screening
T Sakai et al.
JOURNAL OF ANTIBIOTICS (2004)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
